Recent Press Releases

AVEO Oncology Announces New Corporate Headquarters in Cambridge, Massachusetts

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- AVEO Oncology (AVEO) today announced the relocation of its corporate headquarters to One Broadway in Cambridge, Massachusetts, effective today. Consistent with the...

Alnylam Initiates Phase 1 Clinical Trial for ALN-AS1, an Investigational RNAi Therapeutic Targeting Aminolevulinic Acid Synthase 1 (ALAS1) for the Treatment of Acute Hepatic Porphyrias, Including Acute Intermittent Porphyria (AIP)

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, announced today that it has initiated a Phase 1 clinical trial with ALN-AS1, a...

NeuroVive Asia Signs Collaboration Agreement with Sanofi for the Development and Commercialization of Ciclomulsion® in South Korea

STOCKHOLM--Regulatory News: NeuroVive Pharmaceutical AB (STO:NVP), the mitochondrial medicine company, announces that NeuroVive Pharmaceutical Asia group has signed a collaboration agreement with...

FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD

RIDGEFIELD, Conn., May 26, 2015 -- Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) approved once-daily STIOLTO™ RESPIMAT® (tiotropium bromide and...

Amicus Therapeutics' Fabry Monotherapy Granted Accelerated Assessment by European Regulators

First Investigational Therapy for Fabry Disease to be Granted Accelerated Assessment Planned MAA Submission on Track for 2Q15 to Request Full Approval in European Union CRANBURY, N.J., May 26,...

Amgen to terminate participation in co-development and commercialization of brodalumab

Amgen to terminate participation in co-development and commercialization of brodalumab THOUSAND OAKS, Calif., May 22, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Company has...

GSK submits Japan regulatory application for mepolizumab in severe eosinophilic asthma

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the submission of a regulatory application to the Japanese Ministry of Health, Labour and Welfare (MHLW) for mepolizumab as an add-on maintenance...

Omidria® Receives Positive Opinion from European Medicines Agency's Committee for Medicinal Products for Human Use

SEATTLE, May 22, 2015 -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for both...

Cellular Biomedicine Group Announces Positive Phase I Results From CAR-T CD30 Immuno-Oncology Clinical Development Program

SHANGHAI, China and PALO ALTO, Calif., May 22, 2015 -- Cellular Biomedicine Group Inc. (CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of effective...

Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx

SHANGHAI -- A consortium ("the Consortium") consisting of entities affiliated with Shanghai Fosun Pharmaceutical Group, HOPU Investments, China Everbright Limited's healthcare fund...

Novartis announces two positive US phase III programs in COPD for QVA149 and NVA237

QVA149 improved lung function, breathlessness and health-related quality of life in moderate-to-severe COPD patients, according to EXPEDITION trial results[1]-[7] GEM 1 & 2 studies showed...

Nabriva Appoints Elyse Seltzer MD As Chief Medical Officer

Dr William Prince appointed to role of Senior Vice President, Clinical Science Vienna / Philadelphia, 21 May 2015: Nabriva Therapeutics AG, a clinical stage biopharmaceutical company engaged in the...

Mitogenetics Hires Innovative Team Of Scientists To Help Lead Breakthrough In Mitochondrial Dysfunction Research

Mitogenetics, a biomedical technology firm headquartered in South Dakota, today announced the hiring of four scientists to help accelerate the innovation that will lead to major breakthroughs in...

James S. Shannon Rejoins MannKind Corporation (MNKD)'s Board of Directors

VALENCIA, Calif., May 21, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that James S. Shannon, MD, MRCP (UK) has been elected to the company's Board of Directors...

Advaxis, Inc. Appoints Fred J. Frullo Vice President, Regulatory Affairs

PRINCETON, N.J., May 21, 2015 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today announced that it has appointed Fred J....

Bruker Corporation Announces Resignation Of Chief Financial Officer And Appointment Of Interim Chief Financial Officer

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (NASDAQ: BRKR) today announced that on May 19, 2015, Mr. Charles F. Wagner, Jr., Executive Vice President and the Chief Financial Officer (CFO)...

Synereca Pharmaceuticals Appoints Dr. Mark Corrigan To Its Board Of Directors

OKLAHOMA CITY, May 20, 2015 /PRNewswire/ -- Synereca Pharmaceuticals, Inc. (SPI), a research-stage biopharmaceutical company developing compounds that restore or increase the effectiveness of...

OvaScience Announces Ravi Mehrotra, Ph.D., Joins as Chief Corporate Development Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ:OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that...

MPM Capital Appoints Pablo J. Cagnoni, M.D., Former Onyx (AMGN) President, As Managing Director And CEO Of MPM Immunotherapy Portfolio Company Vesuvius.

SAN FRANCISCO--(BUSINESS WIRE)--MPM Capital announces the appointment of former President of Onyx Pharmaceuticals Pablo J. Cagnoni, M.D. as Managing Director (MD). In addition to serving as an MPM...

amp biosimilars AG Strengthens Management And Supervisory Boards

- Gunnar Janssen switching from the Supervisory as CFO to the Management Board - Dr Thomas Zimmer (formerly with Boehringer Ingelheim) appointed new Chairman of the Supervisory Board - Strengthening...